Clearly I am not an immunologist, and this is way out on a limb, but.... couldn't it actually be optimal for the people who receive it? Because, while some vaccines may lead to short-term immunity with a narrow range of antibody production, having the disease itself might lead to longer-term immunity with a much broader range of antibodies. Similar to getting the Singapore strain with the ORF8 deletion: an unimpaired immune response to the full range of viral proteins, with much less severe clinical impact.

My concern is what happens in the later stages after immunization, a year or two down the road, when the vaccine-related immune response is only selectively effective. There are a lot of unknowns with a virus that torpedoes critical early stages of the immune response.